Related Experiment Video
Updated: Mar 31, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
Virological Mechanisms in the Coinfection between HIV and HCV
Maria Carla Liberto1, Emilia Zicca1, Grazia Pavia1
1Department of Health Sciences, Institute of Microbiology, School of Medicine, University of "Magna Graecia", Viale Europa, Germaneto, 88100 Catanzaro, Italy.
Insights
Coinfection with Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) is common. This review explores the complex virological and immunological interactions between HIV and HCV, impacting disease progression and host defenses.
Area of Science:
- Immunology
- Virology
- Hepatology
Background:
- Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) share transmission routes, leading to frequent coinfection.
- HIV significantly accelerates the progression of HCV-related liver disease, increasing risks of cirrhosis and hepatocellular carcinoma.
- HCV coinfection can exacerbate HIV-related immune deficiencies and increase the risk of comorbidities.
Purpose of the Study:
- To review the intricate virological and immunological mechanisms underlying the pathogenesis of HIV/HCV coinfection.
- To elucidate the cross-talk between HIV and HCV proteins in coinfected individuals.
- To understand how these interactions modulate viral life cycles, immune responses, and host defense.
Main Methods:
- Literature review of existing studies on HIV/HCV coinfection.
- Analysis of virological and immunological data from relevant research.
- Focus on the molecular and cellular interactions between the two viruses.
Main Results:
- HIV exacerbates HCV pathogenesis, leading to more severe liver disease.
- HCV can worsen HIV-induced immune defects and increase comorbidity risk.
- A specific cross-talk between HIV and HCV proteins influences disease natural history and viral replication.
Conclusions:
- The interaction between HIV and HCV is multifactorial, involving complex virological and immunological crosstalk.
- Understanding these mechanisms is crucial for managing coinfected patients and improving treatment strategies.
- Interference with host defense mechanisms by viral interactions highlights the need for targeted therapeutic interventions.
Abstract:
Due to shared transmission routes, coinfection with Hepatitis C Virus (HCV) is common in patients infected by Human Immunodeficiency Virus (HIV). The immune-pathogenesis of liver disease in HIV/HCV coinfected patients is a multifactorial process. Several studies demonstrated that HIV worsens the course of HCV infection, increasing the risk of cirrhosis and hepatocellular carcinoma. Also, HCV might increase immunological defects due to HIV and risk of comorbidities. A specific cross-talk among HIV and HCV proteins in coinfected patients modulates the natural history, the immune responses, and the life cycle of both viruses. These effects are mediated by immune mechanisms and by a cross-talk between the two viruses which could interfere with host defense mechanisms. In this review, we focus on some virological/immunological mechanisms of the pathogenetic interactions between HIV and HCV in the human host.
Related Concept Videos
Hepatitis
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Viruses with RNA Genomes
Retrovirus Life Cycles
Size and Structure of Viral Genomes

